Company Filing History:
Years Active: 2022
Title: Adela Matesanz Marín: Innovator in Cardiomyopathy Diagnosis
Introduction
Adela Matesanz Marín is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of medical diagnostics, particularly in the area of cardiomyopathies. Her innovative approach has the potential to improve the accuracy of diagnosing heart conditions.
Latest Patents
Adela holds a patent for a method that provides an in vitro approach for diagnosing cardiomyopathies. This method utilizes expression levels of specific miRNAs, namely miR-721 and miR-155, obtained from a biological sample, preferably plasma. By comparing these expression levels with reference values, the method aims to determine the presence or absence of cardiomyopathy in a human subject. This patent represents a significant advancement in the diagnostic capabilities for heart diseases.
Career Highlights
Throughout her career, Adela has worked with esteemed institutions such as the Centro Nacional de Investigaciones Cardiovasculares Carlos III. Her work in these organizations has allowed her to focus on innovative research that bridges the gap between molecular biology and clinical applications.
Collaborations
Adela has collaborated with notable colleagues, including María Pilar Martín Fernández and Raquel Sánchez Díaz. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field of cardiology.
Conclusion
Adela Matesanz Marín is a trailblazer in the realm of cardiomyopathy diagnostics, with her patented method showcasing her commitment to advancing medical science. Her contributions are poised to make a lasting impact on the diagnosis and treatment of heart conditions.